JP2014201567A5 - - Google Patents

Download PDF

Info

Publication number
JP2014201567A5
JP2014201567A5 JP2013080906A JP2013080906A JP2014201567A5 JP 2014201567 A5 JP2014201567 A5 JP 2014201567A5 JP 2013080906 A JP2013080906 A JP 2013080906A JP 2013080906 A JP2013080906 A JP 2013080906A JP 2014201567 A5 JP2014201567 A5 JP 2014201567A5
Authority
JP
Japan
Prior art keywords
extract
active ingredient
cashew
food composition
kashuimo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013080906A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014201567A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013080906A priority Critical patent/JP2014201567A/ja
Priority claimed from JP2013080906A external-priority patent/JP2014201567A/ja
Publication of JP2014201567A publication Critical patent/JP2014201567A/ja
Publication of JP2014201567A5 publication Critical patent/JP2014201567A5/ja
Pending legal-status Critical Current

Links

JP2013080906A 2013-04-09 2013-04-09 Glp−1分泌促進剤 Pending JP2014201567A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013080906A JP2014201567A (ja) 2013-04-09 2013-04-09 Glp−1分泌促進剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013080906A JP2014201567A (ja) 2013-04-09 2013-04-09 Glp−1分泌促進剤

Publications (2)

Publication Number Publication Date
JP2014201567A JP2014201567A (ja) 2014-10-27
JP2014201567A5 true JP2014201567A5 (enExample) 2016-06-30

Family

ID=52352330

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013080906A Pending JP2014201567A (ja) 2013-04-09 2013-04-09 Glp−1分泌促進剤

Country Status (1)

Country Link
JP (1) JP2014201567A (enExample)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4021505B2 (ja) * 1995-03-27 2007-12-12 徹 赤羽 糖尿病治療薬及び機能性食品
JP2002154978A (ja) * 2000-11-17 2002-05-28 Uma:Kk 血糖降下物質及びその機能性食品
JP2005008572A (ja) * 2003-06-19 2005-01-13 Yakult Honsha Co Ltd リパーゼ阻害剤
JP5794678B2 (ja) * 2010-06-16 2015-10-14 株式会社東洋新薬 グルカゴン様ペプチド−1分泌促進剤
JP2012131742A (ja) * 2010-12-22 2012-07-12 Kao Corp Glp−1分泌促進剤

Similar Documents

Publication Publication Date Title
EP4501932A3 (en) Kras g12c inhibitors
DOP2018000182A (es) Benzamidas sustituidas con 1,3–tiazol–2–ilo
FI3328843T3 (fi) 1,3,4-oksadiatsolisulfonamidijohdannaisyhdisteitä histonideasetylaasi-6:n inhibiittoreina ja samaa käsittävä farmaseuttinen koostumus
MA55571A (fr) Compositions pharmaceutiques comprenant n-(3,5-dimethoxyphenyl)-n'-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine
WO2012051318A8 (en) Sulphonamide compounds and methods of making and using same
WO2012177757A3 (en) Personal care compositions comprising shaped abrasive particles
EA201190145A1 (ru) Фармацевтические композиции, содержащие основание прасугреля или его фармацевтически приемлемые соли присоединения кислоты, и способы их приготовления
EP4335418A3 (en) Compositions and methods for treating pterygium
WO2013103919A8 (en) Compositions and methods for treating metabolic disorders
EP3808367A3 (en) Targeting aneurysm disease by modulating phagocytosis pathways
WO2017022962A8 (ko) Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
WO2016149501A3 (en) Modified therapeutic agents and compositions thereof
AU2014375637A1 (en) Formula of neuregulin preparation
FR3024037B1 (fr) Ingredient actif cosmetique ou dermatologique comprenant un melange d'acides dicarboxyliques gras insatures, compositions le comprenant et utilisations cosmetiques ou dermatologiques
PL3232780T3 (pl) Kompozycje adiuwantowe zawierające wodny elektrolit, kompozycje zawierające składnik czynny i ich zastosowanie
BR112012019351A2 (pt) composição de combinação, que inclui como ingredientes ativos l-carnitina ou propionil l-carnitina, para a prevenção ou tratamento de insuficiência venosa crônica.
WO2016040169A3 (en) Mucolytic agents for use in tretaing pulmonary sarcoidosis
MX2017002968A (es) Anticuerpo monoclonal humanizado para inhibir la actividad enzimatica de la lipasa endotelial vascular.
IL269884B1 (en) Gamkaban its accepted pharmaceutical salts, their compositions and methods of their use
CR20160353A (es) Inhibidor de proteína de transferencia del éster de colesterilo (cetp) y composiciones farmacéuticas que comprenden el inhibidor para uso en el tratamiento o prevención de enfermedades cardiovasculares
PL3019182T3 (pl) Kompozycja zawierająca oczyszczony wyciąg wyodrębniony z pseudolysimachion rotundum var. subintegrum zawierający dużą ilość składnika czynnego lub związki z niego wyodrębnione jako składnik czynny do zapobiegania lub leczenia przewlekłej obturacyjnej choroby płuc oraz jej zastosowania
JP2014201567A5 (enExample)
WO2012102560A3 (ko) 신규한 4-o-메틸호노키올 유도체 및 이를 유효성분으로 포함하는 염증질환 치료용 조성물
JP2014101346A5 (enExample)
JP2014201568A5 (enExample)